Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.60p
   
  • Change Today:
      0.100p
  • 52 Week High: 12.20
  • 52 Week Low: 2.26
  • Currency: UK Pounds
  • Shares Issued: 1,068.00m
  • Volume: 2,101,690
  • Market Cap: £113.21m
  • Beta: 0.70

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

Key Personnel

CEO: Anders Lundstrom
Independent Non-Executive Director: Fabiana Lacerca Allen
Independent Non-Executive Director: Peter Llewellyn-Davies
Non-Executive Chairman: Hans-Peter Hasler
Non-Executive Dir: Rudolf Widmann, Christian Schweiger

Contact Details

Address: Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF
Phone: +44 (0) 191 511 8500
Website: http://www.shieldtherapeutics.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BYV81293

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 10.60p
Change Today 0.100p
% Change 0.95 %
52 Week High 12.20
52 Week Low 2.26
Volume 2,101,690
Shares Issued 1,068.00m
Market Cap £113.21m
Beta 0.70

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average
70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average
Price Trend
58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average
77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average
Income Not Available
Growth
64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 13-Feb-2026

Time Volume / Share Price
17:05 400,000 @ 10.60p
16:35 2,000 @ 10.60p
16:35 2,000 @ 10.60p
16:22 7,000 @ 10.95p
16:16 10,000 @ 10.95p

STX Key Personnel

CEO Anders Lundstrom

Top of Page